IRIS Institutional Research Information System - OPENBS Open Archive UniBS

GENNARELLI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.798
AS - Asia 8.813
EU - Europa 7.724
SA - Sud America 2.048
AF - Africa 187
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 24
AN - Antartide 1
Totale 37.622
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.513
CN - Cina 3.254
SG - Singapore 2.751
UA - Ucraina 1.990
BR - Brasile 1.728
PL - Polonia 1.123
HK - Hong Kong 1.101
IT - Italia 1.046
DE - Germania 1.045
VN - Vietnam 657
FI - Finlandia 531
GB - Regno Unito 517
FR - Francia 452
TR - Turchia 361
RU - Federazione Russa 329
IE - Irlanda 325
IN - India 195
AR - Argentina 140
CA - Canada 131
BD - Bangladesh 108
MX - Messico 95
ZA - Sudafrica 72
SE - Svezia 64
ID - Indonesia 61
IQ - Iraq 56
EC - Ecuador 51
ES - Italia 47
NL - Olanda 46
BE - Belgio 42
CZ - Repubblica Ceca 40
AT - Austria 38
JP - Giappone 32
VE - Venezuela 32
MA - Marocco 30
PK - Pakistan 30
SA - Arabia Saudita 30
CO - Colombia 27
PY - Paraguay 27
AU - Australia 24
CL - Cile 22
KE - Kenya 22
EU - Europa 21
IR - Iran 21
UZ - Uzbekistan 21
LT - Lituania 19
EG - Egitto 18
JO - Giordania 16
CH - Svizzera 14
AE - Emirati Arabi Uniti 13
IL - Israele 13
TN - Tunisia 12
JM - Giamaica 11
PE - Perù 10
BG - Bulgaria 9
NP - Nepal 9
PA - Panama 9
AZ - Azerbaigian 8
DO - Repubblica Dominicana 8
HN - Honduras 8
KR - Corea 8
KZ - Kazakistan 8
MU - Mauritius 8
OM - Oman 8
UY - Uruguay 8
AL - Albania 7
DZ - Algeria 7
KG - Kirghizistan 7
BH - Bahrain 6
CR - Costa Rica 6
ET - Etiopia 6
HU - Ungheria 6
RO - Romania 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
PH - Filippine 5
AO - Angola 4
BY - Bielorussia 4
GE - Georgia 4
LU - Lussemburgo 4
NO - Norvegia 4
PT - Portogallo 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
BB - Barbados 3
BO - Bolivia 3
DK - Danimarca 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
LK - Sri Lanka 3
PS - Palestinian Territory 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
CI - Costa d'Avorio 2
GA - Gabon 2
GT - Guatemala 2
KW - Kuwait 2
LV - Lettonia 2
MY - Malesia 2
NI - Nicaragua 2
BA - Bosnia-Erzegovina 1
Totale 37.606
Salva come PNG Salva come JPEG
Città #
Fairfield 2.491
Woodbridge 1.991
Ashburn 1.466
Jacksonville 1.431
Singapore 1.364
Houston 1.285
Warsaw 1.117
Hong Kong 1.096
Ann Arbor 1.076
Cambridge 1.007
Seattle 941
Wilmington 831
Chandler 654
Beijing 602
Princeton 602
Nanjing 517
New York 363
Dublin 320
Brescia 311
Los Angeles 310
Istanbul 290
Ho Chi Minh City 241
Dearborn 230
Helsinki 219
Nanchang 212
Des Moines 204
The Dalles 197
Munich 171
Shenyang 157
São Paulo 155
Buffalo 152
Changsha 141
Hebei 139
San Diego 132
Moscow 125
Milan 119
Hanoi 115
Redondo Beach 115
Shanghai 115
Lancaster 106
Jinan 104
San Francisco 102
Chicago 95
Tianjin 91
Jiaxing 85
Dallas 77
London 70
Dong Ket 68
Kunming 64
Verona 63
Turku 61
Hangzhou 58
Norwalk 57
Boardman 55
Santa Clara 52
Zhengzhou 52
Guangzhou 50
Lanzhou 50
Rio de Janeiro 49
Ningbo 47
Belo Horizonte 46
Brooklyn 45
Council Bluffs 44
Nuremberg 44
Toronto 44
Brussels 41
Mexico City 41
Johannesburg 40
Haikou 39
Montreal 36
Romola 34
San Mateo 34
Bolzano 33
Denver 32
Rome 31
Haiphong 30
Brasília 29
Orem 29
Jakarta 28
Stockholm 28
Tokyo 28
Atlanta 27
Leawood 27
Phoenix 27
Brno 26
Porto Alegre 25
Campinas 24
Kocaeli 24
Salvador 23
Augusta 22
Washington 22
Fuzhou 21
Nairobi 21
Curitiba 20
Dhaka 20
Frankfurt am Main 20
Hefei 20
Boston 19
Charlotte 19
Fortaleza 19
Totale 25.642
Salva come PNG Salva come JPEG
Nome #
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 311
New Copy Number Variations in Schizophrenia 304
Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling 299
Compound heterozygosity for a large CNV deletion and a rare missense mutation in the FSTL5 gene of a patient affected by schizophrenia. 274
The effect of childhood trauma on blood transcriptome expression in major depressive disorder 253
Mutation within TARDBP leads to Frontotemporal Dementia without motor neuron disease. 235
Genome-wide analysis of consistently RNA edited sites in human blood reveals interactions with mRNA processing genes and suggests correlations with cell types and biological variables 227
Compound heterozygosity for a hemizygous rare missense variant (rs141999351) and a large CNV deletion affecting the FSTL5 gene in a patient with schizophrenia 213
Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood 206
Copy number variants in attention-deficit hyperactive disorder: identification of the 15q13 deletion and its functional role. 203
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 203
Acute Footshock Stress Induces Time-Dependent Modifications of AMPA/NMDA Protein Expression and AMPA Phosphorylation 202
Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder Patients 202
Genomic restricted maximum likelihood (GREML) analysis to estimate the heritability of response/resistance in major depressive disorder (MDD) 197
New biological pathways for major depression: gene expression decomposition in G x E components 194
Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans. 192
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 191
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 186
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 182
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 182
The role of the potassium channel gene KCNK2 in major depressive disorder 178
Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment. 177
Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder 174
Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. 173
TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. 172
Association study and mutational screening of SYNGR1 as a candidate susceptibility gene for schizophrenia 170
Gene per la neuregulina 1 e schizofrenia: ulteriori evidenze di associazione 170
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 170
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 167
A genome-wide investigation of SNPs and CNVs in schizophrenia. 163
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD 163
A putative regulatory subunit (NR3A) of the NMDA receptor complex as candidate gene for susceptibility to schizophrenia: a case-control study. 161
The role of GRIK4 gene in treatment-resistant depression 161
Glucose metabolism alterations in patients with bipolar disorder 160
3' UTR (AGG)n repeat of glial cell line-derived neurotrophic factor (GDNF) gene polymorphism in schizophrenia. 157
BDNF Val66Met polymorphism and protein levels in amniotic fluid. 156
Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders. 156
The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association study. 155
Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. 155
Analysis of Copy Number Variations in Schizophrenia Italian Patients 154
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients. 154
Next Generation Sequencing Analysis in Early Onset Dementia Patients 154
5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression 153
Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline 'Predictors' and Longitudinal 'Targets' 153
The Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders 153
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 151
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 150
BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects. 149
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 149
A genome-wide pharmacogenomic study of patients with schizophrenia suggests that GRM7 mediates the effects of risperidone on positive symptoms 149
Acute Stress Responsiveness of the Neurotrophin BDNF in the Rat Hippocampus is Modulated by Chronic Treatment with the Antidepressant Duloxetine. 148
Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis. 148
Functional study of a novel homozygous mutation in the GAD1 gene, detected in a patient with schizophrenia. 148
MTHFR: Genetic variants, expression analysis and COMT interaction in major depressive disorder 147
Unraveling epigenomic signatures and effectiveness of electroconvulsive therapy in treatment-resistant depression patients: a prospective longitudinal study 145
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 144
Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. 143
BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients 143
An association of GRIK3 Ser310Ala functional polymorphism with personality traits. 142
The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia 142
Derivation of midbrain dopaminergic neurons from human inducible pluripotent stem cells to model neurological disorders. 140
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders. 140
The Expression of VGF is Reduced in Leukocytes of Depressed Patients and it is Restored by Effective Antidepressant Treatment 139
ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder. 139
Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series 139
Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis. 139
Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels 137
Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus 136
A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial. 136
Long-Term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms. 135
PCLO gene: Its role in vulnerability to major depressive disorder. 135
Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes. 135
Heterozygous TREM2 mutations in frontotemporal dementia 135
Possible Influence of a Non-Synonymous Polymorphism Located in the NGF Precursor on Susceptibility to Late-Onset Alzheimer's Disease and Mild Cognitive Impairment. 135
Immune and metabolic alterations in first episode psychosis (FEP) patients 133
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 133
Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: Comparison with methylphenidate. 132
Serum sortilin-derived propeptides concentrations are decreased in major depressive disorder patients 132
The influence of psychiatric screening in healthy populations selection: a new study and meta-analysis of functional 5-HTTLPR and rs25531 polymorphisms and anxiety-related personality traits. 131
Seizure Adequacy Markers and the Prediction of Electroconvulsive Therapy Response 131
α-Synuclein and Glia in Parkinson’s Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System? 131
Influence of clotting duration on brain-derived neurotrophic factor (BDNF) dosage in serum. 130
TWO PEDIGREES OF AUTOSOMAL DOMINANT ATRIOVENTRICULAR CANAL DEFECT (AVCD): EXCLUSION FROM THE CRITICAL REGION ON 8p. 130
VEGF Haplotypes are Associated with Increased Risk to Progressive Supranuclear Palsy and Corticobasal Syndrome. 130
INFLAMMATORY AND NEUROTROPHIC FACTORS UNBALANCE IN LEUKOCYTES OF FIRST EPISODE PSYCHOSIS PATIENTS 130
Blood microRNA changes in depressed patients during antidepressant treatment. 130
Alterations of Brain-Derived Neurotrophic Factor Serum Levels in Patients with Alcohol Dependence. 129
Genetic variations and association. 129
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD). 129
Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients 129
Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first-episode psychosis 129
miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease 129
GENOTYPING OF SPINAL MUSCULAR ATROPHY FAMILIES WITH LINKED DNA PROBES. 128
STUDY OF THE EFFECTS ON DNA OF ELECTROMAGNETIC FIELDS USING CLAMPED HOMOGENEOUS ELECTRIC FIELD GEL ELECTROPHORESIS. 128
Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation. 128
Influence of GRIK4 genetic variants on the electroconvulsive therapy response 128
Polymorphic CA repeat in IGF-I gene: lack of association with schizophrenia. 127
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 126
Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: a case-control study. 125
Molecular signature of disease onset in granulin mutation carriers: a gene expression analysis study. 125
Totale 15.995
Salva come PNG Salva come JPEG
Categoria #
all - tutte 186.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 186.595
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.083 0 0 0 0 0 500 213 513 683 414 550 210
2021/20222.396 158 541 56 56 14 98 206 142 172 238 206 509
2022/20232.084 349 12 31 146 190 620 6 208 315 32 94 81
2023/20242.135 127 52 188 131 95 349 60 72 588 37 37 399
2024/20255.439 47 55 82 615 592 516 392 189 513 585 1.034 819
2025/20266.979 1.042 1.622 852 1.769 1.142 552 0 0 0 0 0 0
Totale 38.148